ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JENNIFER KAPO MD

Geriatric Medicine

268

$77.9K

33
16 are 65+

88%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$291
Average prescription price

Avg: $50

MICHAEL GLUCK MD

Geriatric Medicine

4,118

$440K

236
199 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $50

BENJAMIN JAGIELLO M.D.

Geriatric Medicine

4,468

$412K

333
97 are 65+

60%
patients receiving schedule two controlled substances

Avg: 14%

37%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $50

STASA TADIC MD

Geriatric Medicine

1,006

$78.1K

83
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $50

PRIYA VASDEV M.D.

Geriatric Medicine

20,631

$1.59M

620
483 are 65+

26%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $50

JOHN HARETOS M.D.

Geriatric Medicine

5,159

$390K

260
219 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $50

PETER BRIER MD

Geriatric Medicine

8,174

$584K

411
334 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $50

ANTONIA CHADWICK MD

Geriatric Medicine

10,331

$737K

395
342 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $50

CATHERINE CLARKE M.D.

Geriatric Medicine

4,209

$296K

261
237 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $50

ERIC RODRIGUEZ MD

Geriatric Medicine

1,974

$137K

129
122 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $50

SUPRIYO GHOSH MD

Geriatric Medicine

8,955

$599K

526
471 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

SUSAN MOYER MD

Geriatric Medicine

6,899

$459K

513
510 are 65+

4%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

ROBERT GORDON MD

Geriatric Medicine

14,092

$933K

249
241 are 65+

24%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

ANNE YAWMAN MD

Geriatric Medicine

4,044

$268K

149
148 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

RICHARD HAHN MD

Geriatric Medicine

6,282

$415K

353
327 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

GERARD MILLER M.D.

Geriatric Medicine

7,330

$479K

268
252 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

DEBORAH KAHN MD

Geriatric Medicine

4,557

$296K

212
197 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

FRED RUBIN MD

Geriatric Medicine

6,316

$407K

300
295 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

JOHN MARCELIS MD

Geriatric Medicine

2,300

$148K

133
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

SARAH SHINN MD

Geriatric Medicine

13,249

$841K

570
462 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

BOHDAN MARTYNEC M.D.

Geriatric Medicine

13,836

$877K

672
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

MARITZA DE LA PENA MD

Geriatric Medicine

1,248

$77.7K

99
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

JOEL POSNER MD

Geriatric Medicine

7,055

$438K

407
407 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

NOEL BALLENTINE MD

Geriatric Medicine

3,910

$242K

323
265 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

RITA REICHARD MD

Geriatric Medicine

10,844

$670K

318
278 are 65+

27%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank